1982
DOI: 10.1254/jjp.32.921
|View full text |Cite
|
Sign up to set email alerts
|

Effect of geranylgeranylacetone (GGA) on gastric lesions induced by topical aspirin plus HCl.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
8
0

Year Published

1986
1986
2008
2008

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 8 publications
(7 reference statements)
3
8
0
Order By: Relevance
“…TPA is a novel antiuicer drug developed in Japan [3][4][5][6], Murakami et al [3,5,6] found that TPA prevented the gastric hexosamine content from being reduced by cold restraint stress. Terano et al…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…TPA is a novel antiuicer drug developed in Japan [3][4][5][6], Murakami et al [3,5,6] found that TPA prevented the gastric hexosamine content from being reduced by cold restraint stress. Terano et al…”
Section: Discussionmentioning
confidence: 99%
“…Tetraprenylacetone (TPA), a novel antiulcer drug, was developed in Japan [3][4][5][6], This drug has been shown to protect the gastric mucosa in rats against noxious agents by a mechanism that does not involve the inhibition of acid secretion [7], More recent studies suggest that this agent's protective effect is related to its ability to stimulate mucus production [8].…”
mentioning
confidence: 99%
“…Geranylgeranylacetone (GGA) is an example of an available therapeutic drug that has been shown to induce Hsps in several systems. GGA is an isoprenoid that is used clinically for the treatment of gastritis and gastric ulcers (Murakami et al 1981(Murakami et al , 1982a. GGA induces Hsp70 in a variety of tissues, including the gastric mucosa, heart, liver, brain, and cochlea (Hirakawa et al 1996;Ooie et al 2001;Oda et al 2002;Mikuriya et al 2005;Sone et al 2005).…”
Section: Figmentioning
confidence: 99%
“…Tetraprenylacetone (TPA) protects the gastric mucosa against noxious agents such as aspirin [ 1 ], aspirin plus HC1 [2], and abso lute ethanol [3] in rats by a mechanism that does not involve the inhibition of acid secre tion. However, whether TPA can protect the human gastric mucosa against noxious agents is not known.…”
Section: Introductionmentioning
confidence: 99%